Annalisa Chiocchetti
Biographic Data
| ID | 7946760 |
|---|---|
| NAME | Annalisa Chiocchetti |
| GIVEN NAMES | Annalisa |
| FAMILY NAME | Chiocchetti |
| SIGNATURE | CHIOCCHETTI A |
| AFFILIATIONS | Università degli Studi del Piemonte Orientale “Amedeo Avogadro” |
| ORCID | 0000-0002-4349-1087 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Omics approaches open new horizons in major depressive disorder
Major depressive disorder (MDD) is a recurrent episodic mood disorder that represents the third leading cause of disability worldwide. In MDD, several factors can simultaneously contribute to its development, which complicates its diagnosis. According to practical guidelines, antidepressants are the first-line treatment for moderate to severe major depressive episodes. Traditional treatment strategies often follow a one-size-fits-all approach, re…
Circulating Peptidome Is Strongly Altered in Covid-19 Patients
Whilst the impact of coronavirus disease 2019 (COVID-19) on the host proteome, metabolome, and lipidome has been largely investigated in different bio-fluids, to date, the circulating peptidome remains unexplored. Thus, the present study aimed to apply an untargeted peptidomic approach to provide insight into alterations of circulating peptides in the development and severity of SARS-CoV-2 infection. The circulating peptidome from COVID-19 severe…
No prominent works on this page.
Circulating Peptidome Is Strongly Altered in Covid-19 Patients
Whilst the impact of coronavirus disease 2019 (COVID-19) on the host proteome, metabolome, and lipidome has been largely investigated in different bio-fluids, to date, the circulating peptidome remains unexplored. Thus, the present study aimed to apply an untargeted peptidomic approach to provide insight into alterations of circulating peptides in the development and severity of SARS-CoV-2 infection. The circulating peptidome from COVID-19 severe…
Omics approaches open new horizons in major depressive disorder
Major depressive disorder (MDD) is a recurrent episodic mood disorder that represents the third leading cause of disability worldwide. In MDD, several factors can simultaneously contribute to its development, which complicates its diagnosis. According to practical guidelines, antidepressants are the first-line treatment for moderate to severe major depressive episodes. Traditional treatment strategies often follow a one-size-fits-all approach, re…
Bioinformatics (2 works) · Biology (2 works) · Medicine (2 works) · Advanced Proteomics Techniques and Applications (1 work) · Biomedicine (1 work) · Computational biology (1 work) · Coronavirus disease 2019 (COVID-19 (1 work) · Disease (1 work) · Gene (1 work) · Gene expression (1 work)